Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29353777 | 0.97 | CD47 (0.69) | CD47IL23R | |
| SCHEMBL24172455 | 0.97 | CD47 (0.69) | CD47IL23R | |
| SCHEMBL21185976 | 0.94 | IL23R (0.63) | CD47IL23R | |
| SCHEMBL21185972 | 0.86 | IL23R (0.65) | IL23R | |
| SCHEMBL30092992 | 0.85 | IL23R (0.62) | CD47IL23R | |
| SCHEMBL30092995 | 0.85 | IL23R (0.62) | CD47IL23R | |
| Polyphemusin I SCHEMBL30507731 | 0.84 | IL23R (0.76) | IL23R | |
| SCHEMBL29551233 | 0.84 | GHSR (0.55) | CD47IL23R | |
| SCHEMBL30092985 | 0.84 | IL23R (0.63) | CD47IL23R | |
| SCHEMBL30786423 | 0.83 | GHSR (0.62) | IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11142548-B2 | Agents that activate CD47 and their use in the treatment of inflammation | SORBONNE UNIVERSITE (FR) | 2021-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11142548-B2 | Agents that activate CD47 and their use in the treatment of inflammation | CD47, LGALS2, LGALS1 | CD47 1/4885IL23R 1296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.